Our Senior Advisers


Technical Operations

  • Martin Griot Ph.D.

    Former Head of Global Biotech Operations at Novartis. Over 30 years of experience in biopharmaceutical development and commercial manufacturing.

  • Christian Caderas Ph. D.

    Former Head of Global Program Management TechOps at Novartis. Over 30 years of experience in pharmaceutical API manufacturing with a particular emphasis on network strategy and operational effectiveness.

  • Josef Solleder M.Sc.

    Former Head of Technical Operations International at Polpharma and Head of Global Engineering at Sandoz and Hexal. Over 25 years of experience in technical operations and global engineering with a particular focus on manufacturing network optimization and plant design and construction.


Technical Development

  • Hans Bartholomäus Ph.D.

    Former Head of Pharmaceutical Development at Gruenenthal. Over 25 years of experience in pharmaceutical development and drug delivery technologies.

  • Zoltan Sümeghy Ph.D.

    Former Senior Fellow at Novartis Cell and Gene Therapies. Over 30 years of experience on biologics process development with a particular focus on cell and gene therapies.

  • Vincent Bille Ph.D.

    Former Peptide and Formulation BU Head at UCB. Over 25 years of experience in R&D, manufacturing and technology transfer projects of complex synthetic APIs and aseptic fill & finish.

  • Aleksandar Danilovski Ph.D.

    Former Chief Scientific Officer and Head Global R&D and Global Regulatory Affairs at Xellia Pharmaceuticals. Over 25 years of experience in pipeline and portfolio management and technical product development with a particular focus on anti-infectives.


Supply Chain and Regulatory

  • Michael Bock Ph.D.

    Former Head of Strategic Sourcing Finished Products at Bayer Healthcare. Over 30 years of experience in global supply chain, sourcing and third-party operations management.

  • Chris Smith M.Sc.

    Former Deputy Associate Commissioner at US FDA. Over 35 years of experience on Quality Assurance and Regulatory Affairs.

  • Ingrid Schwarzenberger M.Sc.

    Former member of the Biosimilar Medicines Group at Medicines for Europe, Chairperson of the Biosimilars Committee of the IGBA, working closely with the WHO. Over 30 years of experience in global regulatory affairs and regulatory policy.


Quality and Compliance

  • Ina Bach Ph.D.

    Former Inspector of the Swiss Drug Agency (now Swissmedic). Over 30 years of experience in Quality Assurance and Quality Management.

  • Ursula Koller Ph.D.

    Former Inspector of the Austrian Agency for Health and Food Safety (AGES). Over 25 years of experience in Quality Management including audits/inspections, gap analyses, inspection preparation, and CAPA support.

  • Peter Wohlgemuth

    Former Global Head Safety at Novartis. Over 30 years of experience in the pharmaceutical industry with a particular focus on HSE, Energy and Environmental Management.

  • Thurloch O’Criodain Ph.D.

    Former Senior Compliance Officer at Novartis. Over 40 years of experience spanning medical devices, pharmaceutical and biopharmaceutical quality operations.


Commercial Operations

  • Francois Menard Ph.D.

    Former Global Head Business Development at Sandoz. Over 30 years of experience in commercial operations and business development.

  • Udo Meurle MBA

    Former Head Branded Generics Europe at Cipla. Over 30 years of experience in commercial operations and business development for off patent products.

  • Marie-Josèphe Baud MBA

    Over 30 years of experience in the pharmaceutical industry with a particular emphasis on commercial operations in the European generics industry.

  • Jeroen Weites M.Sc.

    Former Chairman of the Board, Group CEO JSC Olainfarm. Over 30 years of senior management experience in the pharmaceutical industry with an emphasis on general and commercial management.

  • Iztok Sever MBA

    Former General Manager at Unichem, Poland, Country Head at Sandoz Rumania and Head of International Markets at Polpharma. Over 30 years of Senior Management experience in the pharmaceutical and generics industry in the CEE region.